Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer

2022Frontiers in PharmacologyJournalOpen access

10.3389/fphar.2022.1016836 Full text45 citations

Authors

8 authors across 4 institutions in 2 countries.

Mengjiao ZhouFirst author
Danfeng Wang
Xiang Li
Ying Cao
Chengxue Yi
Dickson Kofi Wiredu Ocansey
- University of Cape Coast (GH)
Yuling ZhouCorresponding
Fei MaoSenior authorCorresponding

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Drug Transport and Resistance Mechanismslevel 3 · 1.00
Immune Cell Function and Interactionlevel 3 · 0.98
Inflammatory Bowel Diseaselevel 3 · 0.97

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

crossrefseen September 6, 2026
2022 · Frontiers in Pharmacology · 44 citations
10.3389/fphar.2022.1016836
openalexseen September 5, 2026
2022 · Frontiers in Pharmacology · 45 citations
https://openalex.org/W4302304738

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer · Sankore